Drug Trial Radar · NCT02170870
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Last checked: Nov 19, 2026Latest source record: Apr 23, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
104
Actual
Start
Jun 2014
Primary completion
Nov 17, 2017
Study completion Nov 17, 2017
Sponsor
- Lead sponsor
- Mayo ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- First posted
- Jun 23, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to understand why people with indigestion have gastrointestinal symptoms and in particular to understand whether symptoms are related to increased sensitivity to nutrients in the small intestine and to a hormone (GLP1) which is normally released from the small intestine in response to nutrients. We propose to study the contribution of GLP1 to intestinal sensitivity with a drug (exendin 9-39) that blocks the effects of GLP1.
Conditions
- Dyspepsia
- Diabetes Mellitus With Gastrointestinal Symptoms
Interventions
Exendin 9-39Drug
Exendin 9-39 will be administered intravenously (1,200 pmol/kg bolus followed by infusion at 300 pmol/kg/min).
MicrolipidDrug
Lipid infusion {66.7 mL Microlipid (0.5 gm/mL diluted in water to 222 ml).
PlaceboDrug
Normal saline infusion will be prepared to match the appearance of Exendin 9-39
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Intestinal Chemosensitivity to Lipids PerfusionTime frame: Day 1, approximately 2 hours after infusion
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mayo Clinic in Rochester
Rochester, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.